Home › Services › Compliance & quality › Controlled drugs compliance

Controlled drugs compliance for community pharmacies

Advising community pharmacy owners on their controlled drugs regulatory obligations in England and Wales — CD register compliance, prescription requirements, safe custody and destruction.

In summary: Controlled drugs (CDs) are subject to some of the most stringent regulatory requirements in community pharmacy. Errors in CD record keeping, prescription handling, safe custody or destruction procedures can result in GPhC inspection failures, referral to the NHS England Controlled Drugs Intelligence Unit and, in serious cases, criminal liability. TI Pharmacy Consultancy advises community pharmacies in England and Wales on all aspects of controlled drugs compliance.

The regulatory framework for controlled drugs

Controlled drugs in community pharmacy are governed by a complex regulatory framework spanning several pieces of legislation:

  • Misuse of Drugs Act 1971 — the primary legislation governing controlled substances
  • Misuse of Drugs Regulations 2001 — sets out the requirements for CD schedules, prescriptions, registers, safe custody and destruction
  • Health Act 2006 — introduced the Accountable Officer framework for NHS organisations
  • Human Medicines Regulations 2012 — contains prescription requirements for all medicines including CDs

Community pharmacies must comply with requirements across all of these instruments. The specific obligations vary by CD schedule — Schedule 2 CDs have the most stringent requirements, including mandatory CD register entries and safe custody obligations.

What TI Pharmacy Consultancy does

  • Review of CD register compliance — completeness, accuracy, running balances and record retention
  • Review of CD prescription handling — validity requirements for Schedule 2 and 3 CDs
  • Review of safe custody arrangements — cabinet standards, access controls and security
  • Review of CD destruction procedures — Schedule 2 CD destruction witnessed and recorded correctly
  • Staff awareness — advising on team training for CD handling procedures
  • Preparing pharmacies for CD-related GPhC inspection findings
  • Advising on responses to Accountable Officer inquiries or CD Intelligence Unit notifications

Key controlled drug compliance areas

CD register: Mandatory for Schedule 2 CDs. Each entry must be made on the day of supply or receipt. Running balance must be maintained and checked regularly against physical stock. Records must be retained for at least two years.

Prescription requirements: Schedule 2 and 3 CD prescriptions must meet specific legal requirements. As of 1 January 2025, original pack dispensing rules do not apply to Schedule 2–4 CDs — the exact quantity on the prescription must be supplied.

Safe custody: Schedule 2 CDs and certain Schedule 3 CDs must be stored in a locked receptacle complying with the Misuse of Drugs (Safe Custody) Regulations 1973. The standards for CD cabinets are specific and must be met.

Destruction: Schedule 2 CDs can only be destroyed in the presence of an authorised witness. The destruction must be recorded. Patient returns cannot be returned to stock and must be destroyed.

Is your controlled drugs compliance up to standard?

Contact TI Pharmacy Consultancy for a free initial discussion about your CD compliance position. We identify risks before they become inspection failures.

Free initial discussion

Frequently asked questions

Community pharmacies handling controlled drugs must comply with the Misuse of Drugs Act 1971, the Misuse of Drugs Regulations 2001 and the Health Act 2006. The 2001 Regulations set out the requirements for prescriptions, the CD register, safe custody, destruction and record retention. Schedule 2 and 3 CDs have the most stringent requirements. The Human Medicines Regulations 2012 also contain relevant provisions. TI Pharmacy Consultancy advises on the current legislative requirements and their practical implications for community pharmacies.

CD register records must be retained for a minimum of two years from the date of the last entry. In practice, longer retention is recommended given the potential for civil liability claims and the importance of audit trails for regulatory purposes. TI Pharmacy Consultancy advises on record retention requirements as part of controlled drugs compliance reviews.

Prescriptions for Schedule 2 and 3 CDs must contain the patient’s full name, address and (where appropriate) age; the drug name, form and strength; the total quantity in both words and figures; the dose; and the prescriber’s signature and date. As of 1 January 2025, pharmacists can apply original pack dispensing rules for certain medicines, but Schedule 2–4 CDs are exempt — the exact quantity on the prescription must be supplied. TI Pharmacy Consultancy advises on CD prescription validity requirements.

Each NHS organisation and certain other bodies must have a designated Accountable Officer (AO) responsible for ensuring safe management of controlled drugs. For community pharmacies, the relevant AO is typically within the NHS England or ICB structure for their area. The AO has powers to inspect controlled drug records and investigate concerns. TI Pharmacy Consultancy advises on how community pharmacies can maintain compliant CD arrangements that will withstand AO scrutiny.

Controlled drug compliance is assessed as part of GPhC inspections under the governance principle. Issues with CD records, safe custody or destruction procedures can result in a ‘standards not all met’ outcome, requiring an improvement action plan and re-inspection. Serious CD compliance failures may also trigger referral to NHS England’s Controlled Drugs Intelligence Unit. TI Pharmacy Consultancy identifies and addresses CD compliance risks before they reach the inspection stage.